E10i-494
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
Lipid 17 is a novel, highly potent ionizable lipid designed for mRNA delivery within lipid nanoparticles (LNPs) developed by AstraZeneca . Its structure features a secondary amine head group attached to a cyclic ether moiety (specifically, the 2-oxaspiro[3.3]heptan-6-amine head group). It possesses an asymmetric tail architecture: one tail is derived from heptadecan-9-ol (a branched C17 secondary alcohol), while the other tail is a modified nonyl chain (C9) with a key ethyl branch at the 3-position. The linker connecting the head group to the tails has a length equivalent to n=3 (three methylene units) as defined in the study. This specific combination of the secondary amine cyclic ether head group, asymmetric tails, and the ethyl branch at the 3-position of the nonyl chain proved critical for its exceptional performance. When formulated into LNPs and administered intravenously in mice, Lipid 17 demonstrated a remarkable 6-fold increase in functional protein (eGFP) expression in the liver compared to the benchmark lipid MC3, with high statistical significance (P < 0.0001). This makes Lipid 17 one of the most active lipids identified in the study and a promising candidate for liver-targeted mRNA therapeutics.
| CAS No. | Not available |
| Chemical Name | AZD Lipid 17 |
| Synonyms | AZD Lipid-17,Lipid17,Lipid 17 |
| SMILES | CCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCCC(CCCCCCCC(=O)OCCC(CC)CCCCCC)NC1CC2(COC2)C1 |
| Formula | C51H97NO5 |
| M.Wt | 804.34 |
| Purity | >98% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 12.4326 mL | 2.4865 mL | 1.2433 mL |
| 25 mg | 31.0814 mL | 6.2163 mL | 3.1081 mL |
| 50 mg | 62.1628 mL | 12.4326 mL | 6.2163 mL |
| 100 mg | 124.3255 mL | 24.8651 mL | 12.4326 mL |
| 250 mg | 310.8138 mL | 62.1628 mL | 31.0814 mL |
Contact our team with the catalog number and requested quantity.